← All Bills

S488

Manufacturer Disclosure and Transparency Act; an act to amend the General Business Law — 2025-02-25 · Calendar #204

The New York State Senate passed the Manufacturer Disclosure and Transparency Act on a 49-11 vote, with the bill taking direct aim at pay-for-delay agreements that keep lower-cost generic drugs off the market. Sponsored by Sen. Fernandez, the legislation requires drug manufacturers to disclose backroom deals designed to block generic competition and inflate prescription drug costs. Fernandez argued the bill prioritizes patient access to affordable medication over corporate profits, noting that many New Yorkers cannot afford life-saving prescriptions due to anti-competitive practices rather than lack of innovation or supply. The measure will take effect 180 days after becoming law. Eleven senators voted against the bill: Ashby, Borrello, Canzoneri-Fitzpatrick, Gallivan, Griffo, Mattera, Palumbo, Stec, Tedisco, Walczyk, and Weber.
PASSED Ayes: 49 · Nays: 11

Debate Summary

Sen. Fernandez argued that the bill addresses unaffordable prescription drug costs by targeting pay-for-delay agreements, which are backroom deals where brand-name manufacturers pay to keep lower-cost generics off the market. She contended that transparency requirements would prevent drug companies from hiding behind secrecy and prioritize patient access to affordable medication over corporate profits.

Recorded Votes

Recorded votes are predominantly dissenting (nay) votes captured from roll call records.

Senator Vote Party
Ashby nay Republican
Borrello nay Republican
Canzoneri-Fitzpatrick nay Republican
Gallivan nay Republican
Griffo nay Republican
Mattera nay Republican
Palumbo nay Republican
Stec nay Republican
Tedisco nay Republican
Walczyk nay Republican
Weber nay Republican